某冶炼厂工人铅、镉、砷混合暴露与血压的关联

Association between exposure to lead, cadmium, and arsenic and blood pressure in workers from a smelter

  • 摘要:
    背景  职业性铅、镉、砷暴露是引起血压升高的潜在危险因素。目前研究主要集中在单个金属与血压的关系,而实际工作环境中经常存在多种金属的混合暴露,多金属间的相互作用对血压影响及量效关系尚不明确。
    目的  探究职业性铅、镉、砷混合暴露对血压影响的权重和三种金属间交互作用与血压的关联。
    方法  2021年1—12月选取南方地区某冶炼厂工人为研究对象。通过问卷调查和体格检查,收集工人的人口学特征、身高、体重、血压资料;同时采集工人尿样,采用电感耦合等离子体质谱仪检测其尿铅、尿镉、尿砷,并用尿肌酐校正。采用线性回归和逻辑回归分析尿铅、尿镉、尿砷与血压之间关联;采用加权分位数之和回归分析尿铅、尿镉、尿砷与血压的剂量-反应关系及各金属影响血压的权重;采用广义线性回归和相加与相乘交互量表分析上述三种金属影响血压的交互作用。
    结果  本研究共纳入1075名工人,其年龄为(44.68±5.11)岁,工龄为(24.66±5.23)年,男性891名(88.9%),女性184名(17.1%),24.7%工人为饮酒者,45.7%为吸烟者,302名(28.1%)工人为高血压患者,其中37人正在服用高血压药物。工人尿铅、尿镉、尿砷的P50P25P75)质量分数分别为6.11(3.71,11.08)、3.88(2.68,5.44)、26.04(19.99,35.11)μg·g−1。调整混杂因素性别、年龄、工龄、体重指数、吸烟、饮酒、高血压药物服用情况后,铅、镉、砷混合暴露每增加10%,收缩压和舒张压分别增加0.772、0.418 mmHg。尿铅、尿镉、尿砷中,对收缩压和舒张压影响权重最大的均为尿镉,权重(w)=0.523、0.551。尿铅、尿镉交互作用对高血压的发生存在正向交互作用,乘法交互指标(ORint)=1.88(95%CI:1.09~3.63),归因比例(AP)=1.19(95%CI:0.40~8.18)。
    结论  本研究表明铅、镉、砷混合暴露可致血压升高,其中镉发挥主要作用;尿铅、尿镉交互作用对高血压的发生存在正向作用,该交互作用主要是影响收缩压。

     

    Abstract:
    Background  Occupational exposure to lead, cadmium, or arsenic is a potential risk factor for blood pressure elevation. Current studies mainly focus on the relationship between a single metal and blood pressure. However, mixed metal exposure often exists in the actual working environment, and the interactive effects of polymetallic interactions on blood pressure and the dose-effect relationship remain unclear yet.
    Objective  To explore the influence proportion of occupational exposure to lead, cadmium, or arsenic on blood pressure and their interactive effects.
    Methods  From January to December 2021, workers from a smelter in southern China were selected. Demographic characteristics, height, weight, and blood pressure of workers were collected through questionnaire and physical examination. At the same time, their urine samples were collected and the levels of urinary lead, urinary cadmium, and urinary arsenic were detected by inductively coupled plasma mass spectrometry, and corrected by urinary creatinine (Cr). Linear regression and logistic regression were used to analyze the relationship between urinary lead, cadmium, and arsenic and blood pressure. Weighted quantile sum (WQS) regression was applied to evaluate the dose-effect relationship between urinary lead, cadmium, and arsenic exposures and blood pressure and the effect weight of each metal on blood pressure. Generalized linear regression and additive/multiplicative scaling were used to identify interactive effects of the three metals on blood pressure.
    Results  A total of 1075 workers were included in this study, with a mean age of (44.68±5.11) years and mean working seniority of (24.66±5.23) years. There were 891 males (88.9%) and 184 were females (17.1%); 24.7% workers were drinkers and 45.7% workers were smokers; 302 workers (28.1%) reported hypertension and 37 of them were taking antihypertensive drugs. The P50 (P25, P75) levels of urinary lead, urinary cadmium, and urinary arsenic were 6.11 (3.71, 11.08), 3.88 (2.68, 5.44), and 26.04 (19.99, 35.11) μg·g−1, respectively. After adjusting for gender, age, working seniority, body mass index, smoking, drinking, and the usage of antihypertensive drugs, systolic and diastolic blood pressure increased by 0.772 and 0.418 mmHg respectively for 10% increase in lead, cadmium, and arsenic mixed exposure. Urinary cadmium, among the three single exposures, had the greatest effect on systolic and diastolic blood pressure, weight (w)=0.523 and 0.551 respectively. The interaction of urinary lead and urinary cadmium was positively correlated with the occurrence of hypertension, multiplicative interaction OR (ORint)=1.88 (95%CI: 1.09, 3.63), attributable proportion due to interaction (AP)=1.19 (95%CI: 0.40, 8.18).
    Conclusion  This study shows that mixed exposure to lead, cadmium, and arsenic has a positive relationship with blood pressure, in which cadmium plays a major role. Co-exposure to lead and cadmium has a positive interactive effect on hypertension development and systolic blood pressure elevation.

     

/

返回文章
返回